Bansal Pharmachem Pvt. Ltd., a active private limited company, was established on 25 June 1999 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24231DL1999PTC100411. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 96 professional, Its leadership includes Anuj Kumar Bansal (Director), Ekta Bansal (Director), Aman Bansal (Director). Past directors included Anuj Kumar Bansal, Ekta Bansal, Aman Bansal. It holds ₹1.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 16 Chawla Complexa-215 Shakarpur, Vikas Marg, Delhi 92, New Delhi, Delhi.
U24231DL1999PTC100411
100411
25 June 1999
₹0.50 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Bansal Pharmachem Pvt. Ltd. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anuj Kumar Bansal | Director | 01 Nov 2013 | Current |
| Ekta Bansal | Director | 01 Nov 2013 | Current |
| Aman Bansal | Director | 04 Oct 2011 | Current |
| Rashmi Bansal | Director | 04 Oct 2011 | Current |
| Sachin Bansal | Director | 04 Oct 2011 | Current |
| Shubhi Bansal | Director | 04 Oct 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 25 Jan 2014 | Past |
| Pramod Abcsdd | Additional Director | 25 Jan 2014 | Past |
| Pramod Abcsdd | Additional Director | 24 Aug 2012 | Past |
| Pramod Abcsdd | Additional Director | 24 Aug 2012 | Past |
| Pramod Abcsdd | Additional Director | 24 Aug 2012 | Past |
| Pramod Abcsdd | Additional Director | 24 Aug 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bansal Pharmachem Pvt. Ltd., for the financial year ended 2023, experienced significant growth in revenue, with a 12.6% increase. The company also saw a slight improvement in profitability, with a 7.1% increase in profit. The company's net worth Soared by an impressive increase of 19.41%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Bansal Pharmachem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹1,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 May 2010 | Allahabad Bank | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Bansal Pharmachem has a workforce of 96 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Bansal Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bansal Pharmachem's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Bansal Pharmachem Pvt. Ltd. last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Bansal Pharmachem Pvt. Ltd. has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Priyanka Bansal was appointed as a Director was appointed as a Director on 01 Apr 2022 & has been associated with this company since 3 years 8 months . was recorded as a recent event.
Stuti Mittal was appointed as a Director was appointed as a Director on 01 Apr 2022 & has been associated with this company since 3 years 8 months . was recorded as a recent event.
Progress on Sarita Gupta was appointed as a Additional Director was appointed as a Additional Director on 01 Jan 2021 & has been associated with this company since 4 years 11 months . was documented.
The activity Sandeep Gupta was appointed as a Additional Director was appointed as a Additional Director on 01 Jan 2021 & has been associated with this company since 4 years 11 months . was completed.
The CIN of Bansal Pharmachem Pvt. Ltd. is U24231DL1999PTC100411.
Bansal Pharmachem Pvt. Ltd. is headquartered at 16 Chawla Complexa-215 Shakarpur, Vikas Marg, Delhi 92, New Delhi, Delhi.
Bansal Pharmachem Pvt. Ltd. was incorporated on 25 June 1999.
The current directors of Bansal Pharmachem Pvt. Ltd. are
The primary industry of Bansal Pharmachem Pvt. Ltd. is Trade.
Bansal Pharmachem Pvt. Ltd. is unlisted.
The authorized capital of Bansal Pharmachem Pvt. Ltd. is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Bansal Pharmachem Pvt. Ltd. is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX